Biliary tract cancers (BTCs) encompass rare malignancies arising from bile duct and gallbladder epithelial cells. This study investigated Chinese physicians’ understanding of advan
Large real-world retrospective cohort with prospectively collected data, clear PSA endpoints, and adjusted analysis demonstrating consistent superiority of ARSI-based regimens over ADT monotherapy in mCSPC, though limited by surrogate endpoints and lack of hard clinical outcomes.